0 XP   0   0   0

Recticel
Buy, Hold or Sell?

Should you buy, hold or sell Recticel?

I guess you are interested in Recticel. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Recticel

Let's start. I'm going to help you getting a better view of Recticel. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Recticel even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Recticel is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Recticel. The closing price on 2023-02-07 was €17.80 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Recticel Daily Candlestick Chart
Recticel Daily Candlestick Chart
Summary









1. Valuation of Recticel




Current price per share

€17.80

2. Growth of Recticel




Is Recticel growing?

Current yearPrevious yearGrowGrow %
How rich?$419.8m$359.2m$60.6m14.4%

How much money is Recticel making?

Current yearPrevious yearGrowGrow %
Making money$57.4m$67.7m-$10.3m-18.0%
Net Profit Margin5.2%7.6%--

How much money comes from the company's main activities?

3. Financial Health of Recticel




Comparing to competitors in the Specialty Chemicals industry




  Industry Rankings (Specialty Chemicals)  


Richest
#186 / 589

Most Revenue
#77 / 589

Most Profit
#93 / 589

Most Efficient
#310 / 589


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

1.1. Profitability of Recticel.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Recticel earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Recticel to the Specialty Chemicals industry mean.
  • A Net Profit Margin of 5.2% means that €0.05 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Recticel:

  • The MRQ is 5.2%. The company is making a profit. +1
  • The TTM is 5.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.2%TTM5.2%0.0%
TTM5.2%YOY7.6%-2.4%
TTM5.2%5Y4.0%+1.2%
5Y4.0%10Y1.9%+2.1%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2%7.2%-2.0%
TTM5.2%6.1%-0.9%
YOY7.6%7.0%+0.6%
5Y4.0%6.2%-2.2%
10Y1.9%6.2%-4.3%
1.1.2. Return on Assets

Shows how efficient Recticel is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Recticel to the Specialty Chemicals industry mean.
  • 5.1% Return on Assets means that Recticel generated €0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Recticel:

  • The MRQ is 5.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.1%TTM5.1%0.0%
TTM5.1%YOY9.0%-4.0%
TTM5.1%5Y4.9%+0.2%
5Y4.9%10Y2.2%+2.6%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1%1.6%+3.5%
TTM5.1%1.5%+3.6%
YOY9.0%1.6%+7.4%
5Y4.9%1.4%+3.5%
10Y2.2%1.4%+0.8%
1.1.3. Return on Equity

Shows how efficient Recticel is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Recticel to the Specialty Chemicals industry mean.
  • 13.7% Return on Equity means Recticel generated €0.14 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Recticel:

  • The MRQ is 13.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.7%TTM13.7%0.0%
TTM13.7%YOY18.9%-5.2%
TTM13.7%5Y12.3%+1.4%
5Y12.3%10Y5.2%+7.2%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ13.7%3.0%+10.7%
TTM13.7%2.8%+10.9%
YOY18.9%2.9%+16.0%
5Y12.3%2.6%+9.7%
10Y5.2%2.7%+2.5%

1.2. Operating Efficiency of Recticel.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Recticel is operating .

  • Measures how much profit Recticel makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Recticel to the Specialty Chemicals industry mean.
  • An Operating Margin of 4.5% means the company generated €0.04  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Recticel:

  • The MRQ is 4.5%. The company is operating less efficient.
  • The TTM is 4.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ4.5%TTM4.5%0.0%
TTM4.5%YOY8.7%-4.2%
TTM4.5%5Y5.0%-0.5%
5Y5.0%10Y3.2%+1.7%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5%8.5%-4.0%
TTM4.5%7.8%-3.3%
YOY8.7%9.2%-0.5%
5Y5.0%7.8%-2.8%
10Y3.2%6.3%-3.1%
1.2.2. Operating Ratio

Measures how efficient Recticel is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • An Operation Ratio of 0.96 means that the operating costs are €0.96 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Recticel:

  • The MRQ is 0.963. The company is less efficient in keeping operating costs low.
  • The TTM is 0.963. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.963TTM0.9630.000
TTM0.963YOY0.984-0.021
TTM0.9635Y0.966-0.004
5Y0.96610Y0.974-0.008
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9631.607-0.644
TTM0.9631.549-0.586
YOY0.9841.431-0.447
5Y0.9661.369-0.403
10Y0.9741.142-0.168

1.3. Liquidity of Recticel.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Recticel is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Current Ratio of 1.49 means the company has €1.49 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Recticel:

  • The MRQ is 1.492. The company is just able to pay all its short-term debts.
  • The TTM is 1.492. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.492TTM1.4920.000
TTM1.492YOY1.589-0.097
TTM1.4925Y1.234+0.258
5Y1.23410Y1.137+0.098
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4921.794-0.302
TTM1.4921.730-0.238
YOY1.5891.743-0.154
5Y1.2341.672-0.438
10Y1.1371.487-0.350
1.3.2. Quick Ratio

Measures if Recticel is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Recticel to the Specialty Chemicals industry mean.
  • A Quick Ratio of 0.76 means the company can pay off €0.76 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Recticel:

  • The MRQ is 0.763. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.763. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.763TTM0.7630.000
TTM0.763YOY1.096-0.333
TTM0.7635Y0.756+0.006
5Y0.75610Y0.626+0.131
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7630.839-0.076
TTM0.7630.834-0.071
YOY1.0960.864+0.232
5Y0.7560.811-0.055
10Y0.6260.803-0.177

1.4. Solvency of Recticel.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Recticel assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Recticel to Specialty Chemicals industry mean.
  • A Debt to Asset Ratio of 0.63 means that Recticel assets are financed with 62.9% credit (debt) and the remaining percentage (100% - 62.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Recticel:

  • The MRQ is 0.629. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.629. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.629TTM0.6290.000
TTM0.629YOY0.521+0.108
TTM0.6295Y0.618+0.012
5Y0.61810Y0.642-0.024
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6290.442+0.187
TTM0.6290.425+0.204
YOY0.5210.434+0.087
5Y0.6180.429+0.189
10Y0.6420.430+0.212
1.4.2. Debt to Equity Ratio

Measures if Recticel is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Recticel to the Specialty Chemicals industry mean.
  • A Debt to Equity ratio of 170.5% means that company has €1.70 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Recticel:

  • The MRQ is 1.705. The company is just able to pay all its debts with equity.
  • The TTM is 1.705. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.705TTM1.7050.000
TTM1.705YOY1.090+0.615
TTM1.7055Y1.657+0.048
5Y1.65710Y1.857-0.200
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7050.799+0.906
TTM1.7050.757+0.948
YOY1.0900.775+0.315
5Y1.6570.789+0.868
10Y1.8570.810+1.047

2. Market Valuation of Recticel

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Recticel generates.

  • Above 15 is considered overpriced but always compare Recticel to the Specialty Chemicals industry mean.
  • A PE ratio of 35.18 means the investor is paying €35.18 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Recticel:

  • The EOD is 35.747. Good. +1
  • The MRQ is 35.185. Good. +1
  • The TTM is 35.185. Good. +1
Trends
Current periodCompared to+/- 
EOD35.747MRQ35.185+0.562
MRQ35.185TTM35.1850.000
TTM35.185YOY9.486+25.699
TTM35.1855Y18.907+16.278
5Y18.90710Y16.618+2.288
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD35.74747.495-11.748
MRQ35.18549.507-14.322
TTM35.18562.325-27.140
YOY9.48662.396-52.910
5Y18.90761.867-42.960
10Y16.61851.163-34.545
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Recticel.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Recticel:

  • The MRQ is 79.852. Seems overpriced? -1
  • The TTM is 79.852. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ79.852TTM79.8520.000
TTM79.852YOY3.719+76.132
TTM79.8525Y25.549+54.303
5Y25.54910Y16.667+8.881
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ79.8520.271+79.581
TTM79.8520.046+79.806
YOY3.7190.308+3.411
5Y25.5490.022+25.527
10Y16.6670.029+16.638

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Recticel is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 4.81 means the investor is paying €4.81 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Recticel:

  • The EOD is 4.889. Neutral. Compare to industry.
  • The MRQ is 4.812. Neutral. Compare to industry.
  • The TTM is 4.812. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD4.889MRQ4.812+0.077
MRQ4.812TTM4.8120.000
TTM4.812YOY1.789+3.023
TTM4.8125Y2.269+2.543
5Y2.26910Y1.872+0.397
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD4.8891.959+2.930
MRQ4.8122.102+2.710
TTM4.8122.387+2.425
YOY1.7892.116-0.327
5Y2.2691.934+0.335
10Y1.8721.586+0.286
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Recticel compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.350-2.3500%1.063-321%-0.114-95%-0.081-97%
Book Value Growth--1.1691.1690%1.216-4%1.096+7%1.064+10%
Book Value Per Share--3.6413.6410%5.991-39%4.764-24%4.347-16%
Book Value Per Share Growth--0.6080.6080%1.216-50%0.997-39%1.008-40%
Current Ratio--1.4921.4920%1.589-6%1.234+21%1.137+31%
Debt To Asset Ratio--0.6290.6290%0.521+21%0.618+2%0.642-2%
Debt To Equity Ratio--1.7051.7050%1.090+56%1.657+3%1.857-8%
Dividend Per Share--0.1340.1340%0.237-43%0.198-32%0.163-18%
Dividend Per Share Growth--0.5670.5670%1.007-44%1.057-46%1.028-45%
Eps--0.4980.4980%1.130-56%0.600-17%0.285+75%
Eps Growth--0.4410.4410%2.550-83%1.322-67%1.312-66%
Free Cash Flow Per Share--0.9240.9240%-0.458+150%0.204+352%0.077+1102%
Free Cash Flow Per Share Growth--4.0184.0180%-2.172+154%3.248+24%2.805+43%
Free Cash Flow To Equity Per Share--2.4482.4480%-2.957+221%-0.177+107%-0.160+107%
Free Cash Flow To Equity Per Share Growth--2.8282.8280%-15.911+663%-2.802+199%-0.689+124%
Gross Profit Margin--0.1610.1610%0.040+303%-1.032+740%-1.651+1124%
Intrinsic Value_10Y_max--44.397--------
Intrinsic Value_10Y_min--2.187--------
Intrinsic Value_1Y_max--1.688--------
Intrinsic Value_1Y_min--0.226--------
Intrinsic Value_3Y_max--7.175--------
Intrinsic Value_3Y_min--0.678--------
Intrinsic Value_5Y_max--15.200--------
Intrinsic Value_5Y_min--1.123--------
Net Profit Margin--0.0520.0520%0.076-32%0.040+30%0.019+180%
Operating Margin--0.0450.0450%0.087-48%0.050-10%0.032+39%
Operating Ratio--0.9630.9630%0.984-2%0.9660%0.974-1%
Pb Ratio4.889+2%4.8124.8120%1.789+169%2.269+112%1.872+157%
Pe Ratio35.747+2%35.18535.1850%9.486+271%18.907+86%16.618+112%
Peg Ratio--79.85279.8520%3.719+2047%25.549+213%16.667+379%
Price Per Share17.800+2%17.52017.5200%10.720+63%10.134+73%7.895+122%
Price To Total Gains Ratio-8.033-2%-7.906-7.9060%8.247-196%10.184-178%-1.180-85%
Profit Growth--0.8480.8480%2.550-67%1.385-39%1.367-38%
Quick Ratio--0.7630.7630%1.096-30%0.756+1%0.626+22%
Return On Assets--0.0510.0510%0.090-44%0.049+4%0.022+125%
Return On Equity--0.1370.1370%0.189-27%0.123+11%0.052+167%
Revenue Growth--1.2461.2460%0.798+56%1.008+24%0.981+27%
Total Gains Per Share---2.216-2.2160%1.300-270%0.084-2750%0.082-2803%
Total Gains Per Share Growth---1.705-1.7050%3.080-155%1.857-192%1.718-199%
Usd Book Value--419871338.000419871338.0000%359218940.000+17%327961806.200+28%283482200.700+48%
Usd Book Value Change Per Share---2.522-2.5220%1.140-321%-0.123-95%-0.087-97%
Usd Book Value Per Share--3.9063.9060%6.428-39%5.112-24%4.664-16%
Usd Dividend Per Share--0.1440.1440%0.254-43%0.212-32%0.175-18%
Usd Eps--0.5340.5340%1.213-56%0.644-17%0.306+75%
Usd Free Cash Flow--106567141.000106567141.0000%-27448413.000+126%22574847.000+372%9759578.800+992%
Usd Free Cash Flow Per Share--0.9910.9910%-0.491+150%0.219+352%0.082+1102%
Usd Free Cash Flow To Equity Per Share--2.6262.6260%-3.173+221%-0.189+107%-0.172+107%
Usd Price Per Share19.099+2%18.79918.7990%11.503+63%10.874+73%8.471+122%
Usd Profit--57429106.00057429106.0000%67761023.000-15%41674676.200+38%20037953.100+187%
Usd Revenue--1108189035.0001108189035.0000%889293816.000+25%1105857191.400+0%1128239327.600-2%
Usd Total Gains Per Share---2.378-2.3780%1.395-270%0.090-2750%0.088-2803%
 EOD+1 -4MRQTTM+0 -0YOY+13 -305Y+20 -2310Y+24 -19

3.2. Fundamental Score

Let's check the fundamental score of Recticel based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1535.747
Price to Book Ratio (EOD)Between0-14.889
Net Profit Margin (MRQ)Greater than00.052
Operating Margin (MRQ)Greater than00.045
Quick Ratio (MRQ)Greater than10.763
Current Ratio (MRQ)Greater than11.492
Debt to Asset Ratio (MRQ)Less than10.629
Debt to Equity Ratio (MRQ)Less than11.705
Return on Equity (MRQ)Greater than0.150.137
Return on Assets (MRQ)Greater than0.050.051
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Recticel based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose18.100
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2017-12-312018-12-312019-12-312020-12-312021-12-31
Minority Interest  701070107014705-1,524-819
Tax Provision  16,206-5,99410,212-6,0094,203-1784,025-18,360-14,335
Income Tax Expense  16,206-5,99410,212-6,0094,203-1784,025-18,360-14,335



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets1,055,739
Total Liabilities664,433
Total Stockholder Equity389,782
 As reported
Total Liabilities 664,433
Total Stockholder Equity+ 389,782
Total Assets = 1,055,739

Assets

Total Assets1,055,739
Total Current Assets534,855
Long-term Assets534,855
Total Current Assets
Cash And Cash Equivalents 118,367
Net Receivables 155,145
Other Current Assets 303,938
Total Current Assets  (as reported)534,855
Total Current Assets  (calculated)577,450
+/- 42,595
Long-term Assets
Property Plant Equipment 376,009
Goodwill 29,637
Intangible Assets 19,028
Other Assets 72,529
Long-term Assets  (as reported)520,884
Long-term Assets  (calculated)497,203
+/- 23,681

Liabilities & Shareholders' Equity

Total Current Liabilities358,546
Long-term Liabilities305,887
Total Stockholder Equity389,782
Total Current Liabilities
Short-term Debt 58,382
Short Long Term Debt 51,690
Accounts payable 120,247
Other Current Liabilities 164,562
Total Current Liabilities  (as reported)358,546
Total Current Liabilities  (calculated)394,881
+/- 36,335
Long-term Liabilities
Long term Debt 164,782
Capital Lease Obligations 50,415
Other Liabilities 97,382
Long-term Liabilities  (as reported)305,887
Long-term Liabilities  (calculated)312,579
+/- 6,692
Total Stockholder Equity
Common Stock139,909
Retained Earnings 129,176
Other Stockholders Equity 120,697
Total Stockholder Equity (as reported)389,782
Total Stockholder Equity (calculated)389,782
+/-0
Other
Capital Stock139,909
Cash and Short Term Investments 118,367
Common Stock Shares Outstanding 107,486
Liabilities and Stockholders Equity 1,054,215
Net Debt 148,520
Net Invested Capital 606,254
Net Tangible Assets 341,116
Net Working Capital 176,309
Short Long Term Debt Total 266,887



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
> Total Assets 
828,406
829,968
844,225
985,008
946,498
919,296
890,670
898,839
757,906
777,454
728,124
701,388
612,402
637,805
676,650
692,954
730,162
737,057
802,469
698,757
1,055,739
1,055,739698,757802,469737,057730,162692,954676,650637,805612,402701,388728,124777,454757,906898,839890,670919,296946,498985,008844,225829,968828,406
   > Total Current Assets 
395,596
412,772
372,041
420,193
402,526
428,495
407,948
419,821
351,858
375,410
347,106
310,668
235,049
259,651
293,231
301,689
345,603
344,958
300,600
333,665
534,855
534,855333,665300,600344,958345,603301,689293,231259,651235,049310,668347,106375,410351,858419,821407,948428,495402,526420,193372,041412,772395,596
       Cash And Cash Equivalents 
0
0
0
26,468
25,626
24,723
41,049
68,151
41,388
53,938
54,575
27,008
26,237
26,163
55,967
37,174
57,844
39,554
48,479
79,255
118,367
118,36779,25548,47939,55457,84437,17455,96726,16326,23727,00854,57553,93841,38868,15141,04924,72325,62626,468000
       Short-term Investments 
0
0
0
0
0
0
0
293
156
181
205
45
60
75
91
107
123
138
154
170
0
0170154138123107917560452051811562930000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
114,210
114,272
124,409
154,262
165,591
170,356
132,959
150,607
155,145
155,145150,607132,959170,356165,591154,262124,409114,272114,210000000000000
       Inventory 
106,726
104,996
103,300
0
0
0
0
120,035
105,827
113,671
116,002
112,950
91,374
93,166
89,189
88,155
96,640
92,408
95,330
90,619
112,550
112,55090,61995,33092,40896,64088,15589,18993,16691,374112,950116,002113,671105,827120,0350000103,300104,996106,726
       Other Current Assets 
288,870
307,776
268,741
393,725
376,900
403,772
366,899
231,342
204,487
207,620
176,324
170,665
117,378
140,247
147,984
176,253
190,996
212,858
156,637
163,621
303,938
303,938163,621156,637212,858190,996176,253147,984140,247117,378170,665176,324207,620204,487231,342366,899403,772376,900393,725268,741307,776288,870
   > Long-term Assets 
432,810
417,196
472,184
564,815
543,972
490,801
482,722
479,018
406,048
402,044
381,018
390,720
377,353
378,154
383,419
391,265
384,559
392,099
501,869
365,092
520,884
520,884365,092501,869392,099384,559391,265383,419378,154377,353390,720381,018402,044406,048479,018482,722490,801543,972564,815472,184417,196432,810
       Property Plant Equipment 
559,811
578,507
669,249
408,294
381,136
342,262
349,381
336,560
286,789
270,979
255,347
270,905
204,613
202,733
209,681
216,207
226,783
232,543
332,726
248,378
376,009
376,009248,378332,726232,543226,783216,207209,681202,733204,613270,905255,347270,979286,789336,560349,381342,262381,136408,294669,249578,507559,811
       Goodwill 
0
0
0
42,307
43,626
43,616
37,555
39,164
33,311
34,365
34,688
36,818
24,971
25,039
25,922
25,086
24,169
23,354
25,315
24,867
29,637
29,63724,86725,31523,35424,16925,08625,92225,03924,97136,81834,68834,36533,31139,16437,55543,61643,62642,307000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
72,943
74,575
74,241
82,870
76,908
69,422
66,045
0
0
0066,04569,42276,90882,87074,24174,57572,943000000000000
       Intangible Assets 
25,571
30,329
36,025
25,069
21,039
18,838
19,779
20,104
14,301
13,307
12,580
11,216
11,593
12,294
13,377
12,092
12,322
12,045
13,402
14,078
19,028
19,02814,07813,40212,04512,32212,09213,37712,29411,59311,21612,58013,30714,30120,10419,77918,83821,03925,06936,02530,32925,571
       Long-term Assets Other 
-152,572
-191,640
-233,090
25,843
33,457
18,927
19,640
6,194
10,657
11,147
11,841
12,160
14,364
16,754
17,017
17,297
18,259
34,405
40,427
29,260
49,365
49,36529,26040,42734,40518,25917,29717,01716,75414,36412,16011,84111,14710,6576,19419,64018,92733,45725,843-233,090-191,640-152,572
> Total Liabilities 
750,702
748,202
746,394
703,657
695,263
690,893
642,348
665,136
531,948
535,786
479,330
440,764
425,642
471,642
427,690
441,749
468,376
472,079
527,072
363,977
664,433
664,433363,977527,072472,079468,376441,749427,690471,642425,642440,764479,330535,786531,948665,136642,348690,893695,263703,657746,394748,202750,702
   > Total Current Liabilities 
0
0
0
349,453
353,828
381,503
407,793
327,733
277,430
299,912
284,375
251,356
265,455
251,941
316,510
270,214
294,392
341,052
332,264
210,031
358,546
358,546210,031332,264341,052294,392270,214316,510251,941265,455251,356284,375299,912277,430327,733407,793381,503353,828349,453000
       Short-term Debt 
0
0
0
66,276
0
0
0
68,872
47,740
45,691
67,680
47,958
57,311
43,237
107,245
43,299
46,315
89,321
116,760
13,850
58,382
58,38213,850116,76089,32146,31543,299107,24543,23757,31147,95867,68045,69147,74068,87200066,276000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
165,015
9,831
97,384
39,258
44,308
88,616
100,733
2,588
51,690
51,6902,588100,73388,61644,30839,25897,3849,831165,015000000000000
       Accounts payable 
116,143
140,696
122,794
166,900
179,611
173,134
160,443
146,993
114,208
141,887
119,274
104,980
81,720
96,373
94,276
102,929
126,584
90,756
93,008
88,923
120,247
120,24788,92393,00890,756126,584102,92994,27696,37381,720104,980119,274141,887114,208146,993160,443173,134179,611166,900122,794140,696116,143
       Other Current Liabilities 
0
0
0
116,277
174,217
208,369
247,350
111,868
115,482
112,334
97,421
98,418
126,424
112,331
114,989
123,986
121,493
141,774
111,811
94,362
164,562
164,56294,362111,811141,774121,493123,986114,989112,331126,42498,41897,421112,334115,482111,868247,350208,369174,217116,277000
   > Long-term Liabilities 
0
0
0
354,204
341,435
309,390
234,555
337,403
254,518
235,874
194,955
189,408
160,187
219,701
111,180
171,535
173,984
131,027
194,808
153,946
305,887
305,887153,946194,808131,027173,984171,535111,180219,701160,187189,408194,955235,874254,518337,403234,555309,390341,435354,204000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
61,353
77,566
70,817
74,486
77,904
96,321
95,170
83,520
97,382
97,38283,52095,17096,32177,90474,48670,81777,56661,353000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
525
571
1,218
1,865
1,491
920
446
0
0
004469201,4911,8651,218571525000000000000
> Total Stockholder Equity
61,322
59,900
43,835
206,221
171,579
151,997
183,340
210,613
225,529
241,668
248,794
260,624
186,760
166,163
248,960
251,205
261,786
264,978
274,696
334,075
389,782
389,782334,075274,696264,978261,786251,205248,960166,163186,760260,624248,794241,668225,529210,613183,340151,997171,579206,22143,83559,90061,322
   Common Stock
0
0
0
174,270
174,270
176,501
179,342
179,342
179,342
179,342
179,342
72,329
72,368
74,161
134,329
135,156
136,941
138,068
138,494
139,357
139,909
139,909139,357138,494138,068136,941135,156134,32974,16172,36872,329179,342179,342179,342179,342179,342176,501174,270174,270000
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 0-426,631-604,411-569,382-551,840-547,358-580,306-565,435-543,158-637,075-659,032-648,224000000000
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
61,322
0
0
-48,788
-50,120
-49,996
-43,455
-19,951
-21,395
635,371
643,293
825,370
630,186
655,669
692,355
638,552
635,817
656,656
689,386
522,589
120,697
120,697522,589689,386656,656635,817638,552692,355655,669630,186825,370643,293635,371-21,395-19,951-43,455-49,996-50,120-48,7880061,322



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.